SWOT Analysis for Genpharmasec Ltd. - Weakness

Add SWOT widget to your site/app

Buy Zone: Stocks in the buy zone based on days traded at current PE and P/BV

Mid-range Performer (DVM)

Annual Profit Growth higher than Sector Profit Growth

Companies with rising net profit margins - quarterly as well as TTM basis

Turnaround companies- loss to profit QoQ

Effectively using its capital to generate profit - RoCE improving in last 2 years

Growth in Net Profit with increasing Profit Margin (QoQ)

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Companies with Low Debt

Companies with Zero Promoter Pledge

Top Gainers

PE higher than Industry PE

High PE (PE > 40)

Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score

Oversold by Money Flow Index (MFI)

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Declining Net Cash Flow : Companies not able to generate net cash

Near 52 Week Low

Weak Momentum: Price below Short, Medium and Long Term Averages

RSI indicating price weakness

Highest fall from 52 Week High

Near 52 Week Low

Stocks Underperforming their Industry Price Change in the Quarter

Big Deal (Insider and SAST) buys last month greater than 1% of total shares

Companies with improving valuation scores after share price falls

Decline in Quarterly Net Profit with falling Profit Margin (YoY)